Companion Diagnostics Market Analysis By Technology & By Applications 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Companion diagnostics market
Companion Diagnostics Market: By Technology (PCR, Polymerase Chain Reaction (PCR), ISH, IHC, Others) Applications (Breast Cancer, Lung Cancer, Gastric Cancer, Others) End Users (Pharmaceuticals, Laboratries, Research Institutes, Others)-Forecast(2015-2020)
Report Code : HCR 0055
Published: 18 July, 2015   No. of pages: 86

  • Report Description
  • Table of Contents
  • Customization Options
Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients. The companion diagnostic is crucial for the safe and effective use of the drug and have been widely developed for myriad of cancer and other therapies. Each companion diagnostic test is specifically designed to be paired with a specific drug. Such tests can also save significant healthcare costs by targeting the patients with most effective therapy.

In this report different market aspects are explored with particular focus on key market drivers, challenges, constraints and market landscape. The Global market has been thoroughly analyzed and carefully segmented by geographic locations based on major economic and topographical regions.

The market for Companion diagnostics is classified into several categories based on technology, applications and end users.

Polymerase Chain Reaction (PCR) is the biggest revenue generating segment by type of technology used.

Major market players are profiled along with company overview, financial status, business strategies, product portfolio, recent trends and developments.

The prominent players profiled in the companion diagnostics market report are:
  • Abbott Laboratories
  • Advanced Cell Diagnostics Inc.
  • Agilent Technologies, Inc.
  • Biomérieux and Biogenex Laboratories.

The report details current market potential and future market growth in this industry. Overall the report contains the most detailed and in depth segmentation and analysis of the Global Companion diagnostics Market during the forecast period 2015-2020.
1. Companion Diagnostics Market Overview
2. Executive Summary
3. Companion Diagnostics - Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Companion Diagnostics - Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Companion Diagnostics Market – Government Regulations
6. Companion Diagnostics Market – Strategic Analysis
   6.1. Value Chain Analysis
   6.2. Pricing Analysis
   6.3. Opportunities Analysis
   6.4. Product/Market Life Cycle Analysis
7. Companion Diagnostics Market – By Technology
   7.1. Polymerase Chain Reaction (PCR)
   7.2. Sequencing-based
   7.3. In Situ Hybridization (ISH)
   7.4. Immunohistochemistry (IHC)
   7.5. Others
8. Companion Diagnostics Market – By Applications
   8.1. Breast Cancer
   8.2. Lung Cancer
   8.3. Colorectal Cancer
   8.4. Melanoma
   8.5. Gastric Cancer
   8.6. Others
9. Companion Diagnostics Market – By End Users
   9.1. Pharmaceutical Companies
   9.2. Reference Laboratries
   9.3. CRO
   9.4. Hospitals
   9.5. Research Institutes
10. Companion Diagnostics - Market Geographic Analysis
   10.1. Americas
   10.2. Europe
   10.3. APAC
   10.4. ROW
11. Market Entropy
   11.1. New Product Launches
   11.2. M&As, Collaborations, JVs and Partnerships
12. Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolio)
   12.1. Abbott Laboratories 
   12.2. Advanced Cell Diagnostics Inc. 
   12.3. Agilent Technologies, Inc.
   12.4. Biomérieux
   12.5. Biogenex Laboratories
   12.6. Danaher Corporation
   12.7. GE Healthcare
   12.8. Myriad Genetics, Inc.
   12.9. Qiagen N.V.
   12.10. Roche Diagnostics
   12.11. Thermo Fisher Scientific, Inc.
   12.12. R-Biopharm AG
   12.13. Cypher Genomics
   12.14. Flagship Biosciences
   12.15. Applied Proteomics
   12.16. Ignyta, Inc.
   12.17. Madison Vaccines, Inc.
   12.18. Ventana Medical Systems, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports